No common name available
ADVERTISEMENT
- Molecular formula
- C24H27BrN6O5S
- CAS Number
- .null
- IUPAC Name
- 2-[2-(4-bromophenyl)sulfonylethyl]-N-[(4-carbamimidoylcyclohexyl)methyl]-1,3-dioxo-5,8-dihydro-[1,2,4]triazolo[1,2-a]pyridazine-5-carboxamide
- Molecular Weight
- 542.42g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.4500g/cm3
- Appearance
- can vary slightly depending on the purity and method of preparation.
- Synonyms
- SCHEMBL8144049
Identification
Interesting facts
Interesting Facts about 2-[2-(4-Bromophenyl)sulfonylethyl]-N-[(4-carbamimidoylcyclohexyl)methyl]-1,3-dioxo-5,8-dihydro-[1,2,4]triazolo[1,2-a]pyridazine-5-carboxamide
This intriguing compound, often referred to in scientific circles as a potential pharmaceutical agent, has garnered attention for its complex structure and potential medicinal applications. Here are some captivating insights about this compound:
- Multi-Functional Structure: The compound features a triazolo and pyridazine core, which are important scaffolds in medicinal chemistry, known for their various biological activities, including anti-inflammatory and anti-tumor effects.
- Derivatives: It contains a sulfonamide group, which is known for enhancing the pharmacological properties of drugs, making this compound a noteworthy subject for further research into derivatives that might offer superior efficacy.
- Targeting Mechanisms: The unique combination of the bromophenyl and carbamimidoyl functionalities suggests potential utility in targeting specific biological pathways, which could be utilized for developing treatments in serious illnesses.
- Research Potential: Initial studies indicate that compounds with similar structures can act on ion channels or enzymes. This compound could pave the way for new treatments in areas like neurodegenerative diseases, cardiovascular disorders, and cancer.
- Complex Synthesis: The synthetic pathway to create this compound is intricate, involving multiple steps and careful consideration of reaction conditions, which demonstrates the challenges chemists face in developing new pharmaceutical agents.
As researchers continue to explore the full scope of its biological activities, this compound could very well lead to breakthroughs in drug development, heralding a new wave of therapeutic agents.